Olga J.
- Country
- Poland
- Department
- 206-FutureMeds Warszawa Centrum
Research Overview
- Evaluation of AGA2118 Efficacy and Safety in Postmenopausal Osteoporosis: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
- Phase 2 Randomized, Double-Blind, Dose-Finding Study of Petrelintide Versus Placebo in Obesity or Overweight Patients with Weight-Related Comorbidities
- Evaluation of Maridebart Cafraglutide Efficacy and Safety in Adults with Obesity or Overweight Without Type 2 Diabetes Mellitus: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 7 of 154 partner sites.
Specializations
Rheumatology and Autoimmune Disease
Clinical research activity includes inflammatory joint and connective tissue disorders, with involvement in studies of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, systemic lupus erythematosus, and Sjögren’s syndrome.
- Rheumatoid arthritis
- Psoriatic arthritis
- Systemic lupus erythematosus
- Sjögren’s syndrome
- Diffuse cutaneous systemic sclerosis
Additional interest extends to ulcerative colitis, Crohn’s disease, vitiligo, atopic dermatitis, and chronic spontaneous urticaria, reflecting a broad focus on immune-mediated disorders.
Cardiometabolic and Vascular Medicine
The investigator is involved in trials addressing atherosclerotic cardiovascular disease, atrial fibrillation, heart failure, hypertension, dyslipidemia, and hypertriglyceridemia.
- Atherosclerotic cardiovascular disease
- Heart failure
- Hypertension
- Hypertriglyceridemia
- Atrial fibrillation
Research activity also includes obesity, type 2 diabetes mellitus, chronic kidney disease, and metabolic dysfunction-associated steatohepatitis, indicating strong engagement in metabolic and cardiovascular risk reduction.
Hepatology, Gastroenterology, and Renal Disease
Clinical studies cover chronic liver and digestive disorders, including metabolic dysfunction-associated steatohepatitis, non-alcoholic steatohepatitis, primary biliary cholangitis, celiac disease, Crohn’s disease, and ulcerative colitis.
- Metabolic dysfunction-associated steatohepatitis
- Primary biliary cholangitis
- Inflammatory bowel disease
- Chronic kidney disease
- Gastroesophageal reflux disease
There is also involvement in fibrosis, compensated cirrhosis, and proteinuria, highlighting a therapeutic interest in progressive organ damage across liver and kidney conditions.
Neurology, Pain, and Sleep Disorders
Research spans neurological and symptom-focused conditions such as migraine, focal epilepsy, trigeminal neuralgia, chronic low back pain, and insomnia disorder.
- Migraine
- Focal epilepsy
- Trigeminal neuralgia
- Chronic low back pain
- Insomnia disorder
Additional work includes Parkinson’s disease and agitation in dementia, showing a therapeutic range that extends beyond pain control into neurodegenerative and behavioral symptoms.
Pulmonary, Dermatologic, and Oncology Research
Trial involvement also covers chronic obstructive pulmonary disease, respiratory syncytial virus infections, asthma-related cardiopulmonary outcomes, moderate to severe plaque psoriasis, hidradenitis suppurativa, and prurigo nodularis.
- Chronic obstructive pulmonary disease
- Respiratory syncytial virus infections
- Plaque psoriasis
- Atopic dermatitis
- Non-small cell lung cancer
Oncology-related activity includes small-cell lung cancer, metastatic breast cancer, and neuroendocrine tumors, alongside immune-mediated skin disease and respiratory prevention research.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.